Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Kwang Dong Pharmaceutical Revenue

Kwang Dong Pharmaceutical had revenue of 377.60B KRW in the quarter ending March 31, 2025, a decrease of -8.46%. This brings the company's revenue in the last twelve months to 1.61T, up 2.28% year-over-year. In the year 2024, Kwang Dong Pharmaceutical had annual revenue of 1.64T with 8.34% growth.

• Revenue (ttm): 1,605.84B
• Revenue Growth: +2.28%
• P/S Ratio: 0.15
• Revenue / Employee: 1.56B
• Employees: 1,032
• Market Cap: 240.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1,640.72B	126.26B	8.34%
Dec 31, 2023	1,514.45B	82.91B	5.79%
Dec 31, 2022	1,431.55B	93.36B	6.98%
Dec 31, 2021	1,338.18B	94.41B	7.59%
Dec 31, 2020	1,243.77B	5.51B	0.45%